Literature DB >> 22974892

Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation.

F Frongillo1, U Grossi, A W Avolio, G Sganga, E Nure, G Pepe, G Bianco, M C Lirosi, S Agnes.   

Abstract

Among biliary complications, ischemic-type biliary lesions (ITBLs) remain a major cause of morbidity in liver transplant recipients, significantly affecting the chance of survival of both patients and grafts. We retrospectively reviewed 10 years of prospectively collected donor and recipient data from April 2001 to April 2011. We evaluated the incidence of ITBL occurrence, exploring the possible predisposing factors, including donor and recipient data. Two hundred fifty-one grafts were harvested: 222 of them were transplanted at our institution, the remaining 29 (11.6%) discarded by our donor team as showing >40% macrovesicular steatosis. Mild-moderate (20%-40%) macrovesicular steatosis (P < .001) and cold ischemia time (P = .048) significantly increased the risk of ITBL, also as an independent risk factor after multivariate analysis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22974892     DOI: 10.1016/j.transproceed.2012.06.008

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets.

Authors:  Bin Liu; Jing Li; Lu-Nan Yan
Journal:  Clin Dev Immunol       Date:  2013-12-08

2.  Intra-arterial thrombolysis for early hepatic artery thrombosis after liver transplantation.

Authors:  Ting Li; Xiao-Dong Sun; Ying Yu; Guo-Yue Lv
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

3.  Clinical Analysis of Classification and Prognosis of Ischemia-Type Biliary Lesions After Liver Transplantation.

Authors:  Rui Shi; Tong Liu; Zirong Liu; Yamin Zhang; Zhongyang Shen
Journal:  Ann Transplant       Date:  2018-03-20       Impact factor: 1.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.